These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9017169)

  • 1. Immunohistochemical study in breast carcinoma. S100-protein positive cells and neuroendocrine differentiation.
    Zółtowska A; Moszkowska G; Zamorska B; Roszkiewicz A
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):271-7. PubMed ID: 9017169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast.
    Egan MJ; Newman J; Crocker J; Collard M
    Arch Pathol Lab Med; 1987 Jan; 111(1):28-31. PubMed ID: 3026280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of neuroendocrine feature about salivary adenoid cystic carcinoma.
    Sun C; Zhong M; Wang Z; Wang Y
    Chin J Dent Res; 1999 Dec; 2(3-4):65-7. PubMed ID: 10863420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic and cancer cells in the breast tumors--an immunohistochemical study: short communication.
    Lewko B; Zółtowska A; Stepiński J; Roszkiewicz A; Moszkowska G
    Med Sci Monit; 2000; 6(5):892-5. PubMed ID: 11208428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glycogen-rich clear-cell breast carcinoma with neuroendocrine differentiation features].
    Di Tommaso L; Pasquinelli G; Portincasa G; Santini D
    Pathologica; 2001 Dec; 93(6):676-80. PubMed ID: 11785121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal cell interactions and participation of the neuroendocrine markers in tumor development. Immunohistochemical study.
    Zółtowska A; Stepiński J; Kuczkowski J; Kamiński M; Cynowska B; Kruszewski W
    Arch Immunol Ther Exp (Warsz); 1998; 46(4):247-51. PubMed ID: 9779291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100 protein in human mammary tissue--immunoreactivity in breast carcinoma, including Paget's disease of the nipple, and value as a marker of myoepithelial cells.
    Gillett CE; Bobrow LG; Millis RR
    J Pathol; 1990 Jan; 160(1):19-24. PubMed ID: 2156036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
    Masood S; Sim SJ; Lu L
    Cancer Detect Prev; 1992; 16(4):225-35. PubMed ID: 1281040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myoepithelial differentiation markers in salivary gland neoplasia].
    Scarpellini F; Marucci G; Foschini MP
    Pathologica; 2001 Dec; 93(6):662-7. PubMed ID: 11785118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endocrine differentiation in basocellular carcinoma].
    Collina G; Macrì L; Eusebi V
    Pathologica; 2001 Jun; 93(3):208-12. PubMed ID: 11433614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
    Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.
    Joshi MG; Lee AK; Pedersen CA; Schnitt S; Camus MG; Hughes KS
    Mod Pathol; 1996 Jan; 9(1):57-62. PubMed ID: 8821958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
    Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T
    Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-needle aspiration cytology of breast carcinoma with endocrine differentiation.
    Tse GM; Ma TK
    Cancer; 2000 Oct; 90(5):286-91. PubMed ID: 11038425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of breast carcinoma. Immunohistochemical study.
    Zółtowska A
    Arch Immunol Ther Exp (Warsz); 1997; 45(1):101-8. PubMed ID: 9090448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglandular adenosis of the breast. An immunohistochemical comparison with tubular carcinoma.
    Diaz NM; McDivitt RW; Wick MR
    Arch Pathol Lab Med; 1991 Jun; 115(6):578-82. PubMed ID: 1710101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
    Cîmpean AM; Raica M; Nariţa D
    Rom J Morphol Embryol; 2005; 46(2):123-9. PubMed ID: 16286998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical profile and differential diagnosis of microglandular adenosis.
    Tavassoli FA; Bratthauer GL
    Mod Pathol; 1993 May; 6(3):318-22. PubMed ID: 8346180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.